Pieris Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of PIRS for the last quarter is 53.00 k USD, and it's 95.92% lower compared to the previous quarter. The net income of Q1 24 is -4.89 M USD.